July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Oncostatin M (OSM) Contributes to Corneal Epitheliopathy in Tear Deficient Dry Eye Disease due to Chronic ocular Graft-Vs-Host Disease (oGVHD)
Author Affiliations & Notes
  • Christine Mun
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • SEUNGWON AN
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • ILANGOVAN RAJU
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Bayasgalan Surenkhuu
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Satyabrata Sinha
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Pei-Yu Wu
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Anubhav Pradeep
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Anna Ahn
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Jieun Kwon
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Azucena Lopez
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Sandeep Jain
    Ophthalmology & Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   Christine Mun, None; SEUNGWON AN, None; ILANGOVAN RAJU, None; Bayasgalan Surenkhuu, None; Satyabrata Sinha, None; Pei-Yu Wu, None; Anubhav Pradeep, None; Anna Ahn, None; Jieun Kwon, None; Azucena Lopez, None; Sandeep Jain, Advaite (I), Advaite (P), Genentech (F), Ocugen (C), University of Illinois at Chicago (P)
  • Footnotes
    Support  NIH Grant P30EY001792, NIH Grant R01EY023656, NIH Grant R01EY024966, NIH Grant R13EY027189, Research to Prevent Blindness
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3292. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christine Mun, SEUNGWON AN, ILANGOVAN RAJU, Bayasgalan Surenkhuu, Satyabrata Sinha, Pei-Yu Wu, Anubhav Pradeep, Anna Ahn, Jieun Kwon, Azucena Lopez, Sandeep Jain; Oncostatin M (OSM) Contributes to Corneal Epitheliopathy in Tear Deficient Dry Eye Disease due to Chronic ocular Graft-Vs-Host Disease (oGVHD). Invest. Ophthalmol. Vis. Sci. 2018;59(9):3292.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We investigated whether OSM, a Heparin binding protein, is associated with corneal epitheliopathy in oGVHD.

Methods : Ocular surface washings were collected in patients who had “definite” oGVHD or “none” oGVHD following allogeneic bone marrow transplant as well as in age matched healthy subjects, and analyzed for OSM levels using Luminex. Immunofluorescence for OSM was performed on mucocellular aggregrates and cytospin preparations of ocular surface washings. Neutrophil Extracellular Traps (NETs) with or without incubation with OSM neutralizing antibodies (OSM NAb) were applied to naïve murine corneas and epitheliopathy determined with fluorescence staining.

Results : Ocular surface washings of “definite” oGVHD patients had significantly higher levels of OSM as compared to “none” oGVHD patients and healthy subjects. OSM was present in significantly higher levels in supernatant of PMA stimulated neutrophils as compared to non-stimulated neutrophils and RPMI culture media suggesting NETs as the source of OSM. First, we investigated whether reducing OSM levels in naive NETs using OSM NAb abrogates NET-induced epitheliopathy in murine corneas. We applied naive NETs and OSM NAb incubated NETs to naïve murine corneas for five consecutive days. Significantly greater corneal fluorescein staining was observed at Day 5 following application of NETs (7.20 ± 0.97; p<0.05) as compared to OSM NAb incubated NETs (0.40 ± 0.24). At Day 5, corneas were excised and abundance of inflammatory cytokines (IL-1β, IL-6 and IP-10) were determined in lysates. Corneas exposed to NETs had significantly higher abundance of these inflammatory cytokines as compared and OSM NAb incubated NETs. Second, we investigated whether OSM recombinant protein can produce epitheliopathy similar to NETs and whether reducing OSM levels using OSM NAb abrogates that effect. Significantly greater corneal fluorescein staining was observed at Day 5 following application of OSM (8.75 ± 0.48; p<0.05) as compared to OSM incubated with OSM NAb (0.80 ± 0.37).

Conclusions : These interlocking experiments suggest that OSM is a molecular component of NETs and is present in abundance over the ocular surface of “definite” oGVHD patients. OSM is associated with corneal epitheliopathy and inflammation and may be a therapeutic target to reduce epitheliopathy.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×